South Korea · Delayed Price · Currency is KRW DuChemBIO Company Description
DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease.
The company also offers FES, a solution for diagnosis of metastatic breast cancer and determination of estrogen receptor status; FACBC for prostate cancer diagnosis; FDG for the diagnosis of tumors; and NaF for the diagnosis of bone-related diseases.
DuChemBIO Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2002 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 115 |
| CEO | Sang-Woo Kim |
Contact Details
Address: 81, Wausan-ro Seoul, 04041 South Korea | |
| Phone | 82 2 332 4868 |
| Website | duchembio.com |
Stock Details
| Ticker Symbol | 176750 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Sang-Woo Kim | Chief Executive Officer |